Equities

Hiscox Ltd

HSX:LSE

Hiscox Ltd

FinancialsNon-life Insurance
  • Price (GBX)1,217.00
  • Today's Change-13.00 / -1.06%
  • Shares traded1.56m
  • 1 Year change2.96%
  • Beta1.0227
Data delayed at least 20 minutes, as of May 01 2024 16:44 BST.
More ▼

Forecasts data is unavailable for this security.

Consensus recommendation

  • 18-May-23
  • 15-Feb-24
  • 14-Mar-24
  • 18-Apr-24
  • 25-Apr-24
Select bar for recommendation details.
Recommendations25-Apr-24
Buy2
Outperform5
Hold9
Underperform0
Sell0

Share price forecast

The 15 analysts offering 12 month price targets for Hiscox Ltd have a median target of 1,272.12, with a high estimate of 1,576.34 and a low estimate of 971.90. The median estimate represents a 4.53% increase from the last price of 1,217.00.
High29.5%1,576.34
Med4.5%1,272.12
Low-20.1%971.90

Dividends

In 2023, Hiscox Ltd reported a dividend of 0.25 USD, which represents a 30.56% decrease from last year. The 16 analysts covering the company expect dividends of 0.44 USD for the upcoming fiscal year, an increase of 75.60%.
Div growth (TTM)-30.56%
More ▼

Earnings history & estimates

Hiscox Ltd reported annual 2023 earnings of 2.02 per share on Mar 05, 2024.
Average growth rate+750.55%
More ▼

Revenue history & estimates

Hiscox Ltd had revenues for the full year 2023 of 4.48bn. This was 1.32% above the prior year's results.
Average growth rate+2.72%
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.